GEN Exclusives

More »
Thermo Fisher Scientific - Related Content
  • Insight & Intelligence™
  • More »

Thermo Fisher Scientific

UHPLC Separation System

The Dionex™ UltiMate™ 3000 biocompatible rapid separation system is designed to bring flexible UHPLC separation capabilities to a range of biopharmaceutical research and QA/QC analyses. The UltiMate 3000 BioRS system has a selection of modules that

Thermo Fisher Scientific

Sample Prep/LC System

The Prelude SPLC sample preparation and liquid chromatography system was developed to make analysis of target compounds in complex biological matrices routine for clinical research and forensic toxicology laboratories. It is designed to enhance LC-

Thermo Fisher Scientific

Liquid Junction Kit for UHPLC

A UHPLC liquid junction kit is now available for the Nanospray Flex ion source for electrospray ionization LC-MS. The new kit can extend the functionality of the source by elevating packed-tip column performance to UHPLC levels. The Nanospray Flex

Thermo Fisher Scientific

Autosampler for Organic Volatiles

The TriPlus 300 headspace autosampler has been designed for analyzing organic volatiles. This valve-and-loop headspace autosampler features a 120-vial sample tray capacity and 18-vial incubation oven overlap capacity, enabling unattended high-throu

Thermo Fisher Scientific

Bioprocess Container Film

Aegis™ 5-14 premium film is used to manufacture Thermo Scientific™ bioprocess containers for biopharma drug discovery and production. Developed specifically for liquid handling, production, storage, and transportation, Aegis 5-14 is a five-layer, 1

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?